It has been shown that activation of inflammasome and IL-18 signaling pathway has a strong protective effect in colitis-associated colorectal cancer [9], among which NOD-like receptor protein 3 (NLRP3) is one of the most studied inflammasome. Here, NLRP3 is linked to colitis.